IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v12y2021i1d10.1038_s41467-021-21411-0.html
   My bibliography  Save this article

Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013–16 West Africa epidemic

Author

Listed:
  • T. R. W. Tipton

    (Public Health England)

  • Y. Hall

    (Public Health England)

  • J. A. Bore

    (Center for Training and Research on Priority Diseases including Malaria in Guinea (CEFORPAG))

  • A. White

    (Public Health England)

  • L. S. Sibley

    (Public Health England)

  • C. Sarfas

    (Public Health England)

  • Y. Yuki

    (Frederick National Laboratory for Cancer Research in the Laboratory of Integrative Cancer Immunology, National Cancer Institute)

  • M. Martin

    (Frederick National Laboratory for Cancer Research in the Laboratory of Integrative Cancer Immunology, National Cancer Institute)

  • S. Longet

    (Public Health England)

  • J. Mellors

    (Public Health England)

  • K. Ewer

    (The Jenner Institute)

  • S. Günther

    (Bernhard Nocht Institute for Tropical Medicine
    Partner Site Hamburg-Lübeck-Börstel-Riems)

  • M. Carrington

    (Frederick National Laboratory for Cancer Research in the Laboratory of Integrative Cancer Immunology, National Cancer Institute
    Ragon Institute of MGH, MIT, and Harvard)

  • M. K. Kondé

    (Center for Training and Research on Priority Diseases including Malaria in Guinea (CEFORPAG))

  • M. W. Carroll

    (Public Health England
    University of Oxford)

Abstract

Zaire ebolavirus (EBOV) is a highly pathogenic filovirus which can result in Ebola virus disease (EVD); a serious medical condition that presents as flu like symptoms but then often leads to more serious or fatal outcomes. The 2013–16 West Africa epidemic saw an unparalleled number of cases. Here we show characterisation and identification of T cell epitopes in surviving patients from Guinea to the EBOV glycoprotein. We perform interferon gamma (IFNγ) ELISpot using a glycoprotein peptide library to identify T cell epitopes and determine the CD4+ or CD8+ T cell component response. Additionally, we generate data on the T cell phenotype and measure polyfunctional cytokine secretion by these antigen specific cells. We show candidate peptides able to elicit a T cell response in EBOV survivors and provide inferred human leukocyte antigen (HLA) allele restriction. This data informs on the long-term T cell response to Ebola virus disease and highlights potentially important immunodominant peptides.

Suggested Citation

  • T. R. W. Tipton & Y. Hall & J. A. Bore & A. White & L. S. Sibley & C. Sarfas & Y. Yuki & M. Martin & S. Longet & J. Mellors & K. Ewer & S. Günther & M. Carrington & M. K. Kondé & M. W. Carroll, 2021. "Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013–16 West Africa epidemic," Nature Communications, Nature, vol. 12(1), pages 1-9, December.
    • Handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-21411-0
    DOI: 10.1038/s41467-021-21411-0
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-021-21411-0
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-021-21411-0?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-21411-0. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.